In the first comprehensive analysis of clinical trial enrollment among older adults with blood cancers, researchers from the U.S. Food and Drug Administration (FDA) found significant gaps in participation among those aged ...
Dec 12, 2017
0
1
When choosing their preferred treatment, people with chronic lymphocytic leukemia (CLL) place the highest value on medicines that deliver the longest progression-free survival, but are willing to swap some drug efficacy for ...
Nov 22, 2017
0
0
The drug hydroxyurea does not appear to increase the risk of malaria infection in patients with sickle cell anemia who live in malaria-endemic regions, according to a study published online today in Blood, a Journal of the ...
Oct 19, 2017
0
0
An investigational treatment that mimics a key clotting enzyme is effective, safe, and may one day eliminate the need for blood products for people with the rare, life-threatening blood disease hereditary thrombotic thrombocytopenic ...
Sep 14, 2017
0
0
Researchers have developed a two-pronged approach to blood cancer treatment: 1) attacking cancer cells directly and/or 2) driving them from the nurturing bone marrow environment into the peripheral blood streams, where they ...
Jun 21, 2017
0
3
Some patients with relapsed or treatment-resistant acute myeloid leukemia, a form of blood cancer for which there are few treatments, may achieve remission with an experimental targeted therapy, according to early trial data ...
Jun 6, 2017
0
1
In a new analysis, patients with atrial fibrillation showed a substantially reduced risk of dangerous bleeding in the brain, known as intracranial hemorrhage, when taking the newer anticoagulant apixaban compared to those ...
Mar 29, 2017
0
0
New research suggests that young patients with acute lymphocytic leukemia (ALL)—the most common type of pediatric cancer—and their and their parents are likely to report to their physician that they took more of their ...
Feb 2, 2017
0
0
Newborns with congenital cytomegalovirus (CMV)—a common virus in the herpes family—may have an increased risk of developing acute lymphocytic leukemia (ALL), according to new research published online today in Blood, ...
Dec 15, 2016
1
71
Compared with standard therapy, pacritinib significantly reduces spleen size among people with myelofibrosis who have very low levels of platelets, according to a late-breaking study being presented today during the 58th ...
Dec 6, 2016
0
0
